Highly Variable Biodistribution of 68Ga Labeled Somatostatin Analogue DOTA-NOC/TATE in Neuroendocrine Tumors: Clinical Implications for Somatostatin Receptor Directed PET/CT

被引：0
|
作者：
Cheng, Monica [1 ]
Tann, Mark [2 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1019
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Comparison of 68Ga-DOTA-TATE and 68Ga-DOTA-NOC PET/CT imaging in the same patient group with Neuroendocrine Tumors
    Demirci, E.
    Ocak, M.
    Kabasakal, L.
    Decristoforo, C.
    Gunes, B.
    Arslan, E.
    Araman, A.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S281 - S281
  • [12] 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 508 - 518
  • [13] 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 : 189S - 198S
  • [14] [68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications
    Giovannini, Elisabetta
    Giovacchini, Giampiero
    Borso, Elisa
    Lazzeri, Patrizia
    Riondato, Mattia
    Leoncini, Rossella
    Duce, Valerio
    Ciarmiello, Andrea
    CURRENT RADIOPHARMACEUTICALS, 2019, 12 (01) : 11 - 22
  • [15] Ga-68 somatostatin receptor PET/CT in the management of neuroendocrine tumors of the lungs
    Prasad, Vikas
    Pape, Ulrich-Frank
    Pavel, Marianne
    Wiedenmann, Bertram
    Brenner, Winfried
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [16] 68Ga-DOTA-TATE and 68Ga-DOTA-NOC PET in neuroendocrine tumors: First year experience in Turkey
    Demirci, E.
    Ocak, M.
    Kabasakal, L.
    Gunes, B.
    Decristoforo, C.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S281 - S281
  • [17] 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Chordoma
    Derlin, Thorsten
    Sohns, Jan M.
    Hueper, Katja
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : E210 - E211
  • [18] Incidence and detection of cardiac metastases in patients wih neuroendocrine tumors (NET): Role of Ga-68 DOTA-NOC receptor PET/CT
    Prasad, V.
    Secknus, M. A.
    Lauer, B.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S193 - S193
  • [19] Somatostatin Receptor PET in Neuroendocrine Tumors: 68Ga-DOTA-Tyr3-Octreotide vs. 68Ga-DOTA-Lanreotide
    Putzer, D.
    Kroiss, A.
    Waitz, D.
    Gabriel, M.
    Guggenberg, E.
    Uprimny, C.
    Decristoforo, C.
    Warwitz, B.
    Virgolini, I. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S273 - S273
  • [20] Preliminary PET/CT Imaging with Somatostatin Analogs [68Ga]DOTAGA-TATE and [68Ga]DOTAGA-TOC
    Drishty Satpati
    Ajit Shinto
    K. K. Kamaleshwaran
    Haladhar Dev Sarma
    Ashutosh Dash
    Molecular Imaging and Biology, 2017, 19 : 878 - 884
12345